RecruitingNCT07118683

BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS


Sponsor

Hospital Alemão Oswaldo Cruz

Enrollment

743 participants

Start Date

Aug 15, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

BRAVO proposes the establishment of a comprehensive registry of chronic noncommunicable diseases (NCDs), providing crucial data for the formulation of effective health policies for people living with HIV/AIDS (PLWHA). BRAVO is a cross-sectional study, that will collect on the study allocation sociodemographic data, risk factors related to the main NCDs, physical examination data and samples for determination of biochemical and metabolic parameters. To this end, the study will include co-participating research centers from the 5 Brazilian geographic macro-regions.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Adults aged 18 or over;
  • Confirmed HIV or AIDS diagnosis;
  • Signature of consent form.

Exclusion Criteria2

  • Indigenous population or those in prison in open or closed regimes;
  • Patients hospitalized at the time of signing the Consent Form.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(9)

Hospital das Clínicas da Universidade Federal de Goiás

Goiânia, Goiás, Brazil

Faculdade de Medicina da Universidade Federal de Minas Gerais

Belo Horizonte, Minas Gerais, Brazil

Hospital de Clínicas da Universidade Federal do Paraná

Curitiba, Paraná, Brazil

Hospital Federal dos Servidores do Estado do Rio de Janeiro

Rio de Janeiro, Rio de Janeiro, Brazil

Hospital Federal de Santa Maria

Santa Maria, Rio Grande do Sul, Brazil

Centro de Pesquisa Clínica Dom Bosco

Araçatuba, São Paulo, Brazil

Faculdade de Medicina de Botucatu da UNESP

Botucatu, São Paulo, Brazil

Centro Universitário FMABC

Santo André, São Paulo, Brazil

Instituto de Infectologia Emílio Ribas

São Paulo, São Paulo, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07118683


Related Trials